Trading Signals: CEMI Stock Price Prediction and Forecast (Wed. Nov. 26, 2003 - Wed. Jul. 21, 2021)(Chembio Diagnostics Inc)
| CEMI latest price $5.1500 (0.59%) ($5.0000 - $5.2500) on Fri. Aug. 14, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.24% (three month average) | RSI | 50 | Latest Price | $5.1500(0.59%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CEMI declines -1.3% a day on average for past five trading days. | Weekly Trend | CEMI advances 0.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support CEMI advance at 0% a week (0% probability) VCIT(87%) TIP(77%) BWX(55%) LQD(22%) EMHY(20%) | Factors Impacting CEMI price | CEMI will decline at least -5.12% in a week (0% probabilities). UUP(-30%) UNG(-28%) TBT(-22%) DRIV(-9%) TAN(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.12% (StdDev 10.24%) | Hourly BBV | 0.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $5.37 | 5 Day Moving Average | $5.35(-3.74%) | 10 Day Moving Average | $5.52(-6.7%) | 20 Day Moving Average | $5.37(-4.1%) | To recent high | -58.9% | To recent low | 3% | Market Cap | $104m | | | | Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY. |